The future of medicine: a glimpse over the horizon
Despite important innovations in medicine and pharmaceutical science, the negative trend persists: heavy diseases are getting more widespread. This creates new serious challenges for biology, medical science and pharmaceutical companies. The priority action is the development of stem and gene technology products, biogenerics and substitution of innovative drugs with their generic counterparts.